CAR-T IL-1RAP targeting therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR-T IL-1RAP targeting therapy, covering 2026-03-06 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDS [NA]